skip banner navigation
National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Protecting Participants in Clinical Trials
    Updated: 08/30/2001




Introduction






NCI Materials



Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Dictionary

Funding Opportunities

NCI Publications

NCI Calendar

Español
NCI Highlights
Chemo Extends Life in Advanced Prostate Cancer

Temozolomide Plus Radiation Helps Brain Cancer

Confirmed: Raloxifene Drops Risk of Breast Cancer

Bortezomib Delays Progression of Multiple Myeloma

Annual Report to the Nation

Past Highlights
Need Help?
Introduction

The mission of the National Cancer Institute is to improve human health through biomedical and behavioral research. Conducting research involving human participants is a necessary and important part of that mission. Therefore, the NIH is committed to assuring that all of its research activities involving human participants are conducted in a way that promotes their rights and welfare.

The resources listed on this page provide information about the ways in which those who participate in clinical trials are protected before and during the conduct of a study.

Next Section >

skip footer navigation

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health FirstGov.gov